about
Expression profile of immune response genes in patients with Severe Acute Respiratory SyndromeAntiviral actions of interferonsCD8(+) T cell-mediated injury in vivo progresses in the absence of effector T cells.Immune Responses in Acute and Convalescent Patients with Mild, Moderate and Severe Disease during the 2009 Influenza Pandemic in Norway.Coronavirus spike protein inhibits host cell translation by interaction with eIF3fIncrease of Plasma IL-12/p40 Ratio Induced by the Combined Therapy of DNA Vaccine and Lamivudine Correlates with Sustained Viremia Control in CHB Carriers.Gamma interferon-dependent, noncytolytic clearance of sindbis virus infection from neurons in vitroAlpha and gamma interferons inhibit herpes simplex virus type 1 infection and spread in epidermal cells after axonal transmissionDisturbance of tumor necrosis factor alpha-mediated beta interferon signaling in cervical carcinoma cells.Hepatocyte nuclear factor 3beta inhibits hepatitis B virus replication in vivo.Gene therapy strategies for the treatment of chronic viral hepatitis.CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection.Cytokine expression during chronic versus occult hepatitis B virus infection in HIV co-infected individualsThe viral KSHV chemokine vMIP-II inhibits the migration of Naive and activated human NK cells by antagonizing two distinct chemokine receptors.Expression and function of chemokines during viral infections: from molecular mechanisms to in vivo function.Memory T cells persisting in the brain following MCMV infection induce long-term microglial activation via interferon-γ.Tumor necrosis factor activates a conserved innate antiviral response to hepatitis B virus that destabilizes nucleocapsids and reduces nuclear viral DNA.Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells.Immunomodulatory therapy for chronic hepatitis B virus infection.Association of major histocompatibility complex class I haplotypes with disease progression after simian immunodeficiency virus challenge in burmese rhesus macaques.Human immunodeficiency virus type 1 controllers but not noncontrollers maintain CD4 T cells coexpressing three cytokines.T cells cause acute immunopathology and are required for long-term survival in mouse adenovirus type 1-induced encephalomyelitisDNA gag/adenovirus type 5 (Ad5) gag and Ad5 gag/Ad5 gag vaccines induce distinct T-cell response profilesPerforin and gamma interferon-mediated control of coronavirus central nervous system infection by CD8 T cells in the absence of CD4 T cellsAlphaherpesviruses and chemokines: pas de deux not yet brought to perfection.Sorting Out Pandora's Box: Discerning the Dynamic Roles of Liver Microenvironment in Oncolytic Virus Therapy for Hepatocellular Carcinoma.Up-regulation of IL-12 expression in patients with chronic hepatitis B is mediated by the PI3K/Akt pathway.Common antiviral cytotoxic t-lymphocyte epitope for diverse arenaviruses.Characterization of nuclear RNases that cleave hepatitis B virus RNA near the La protein binding siteCan engineered "designer" T cells outsmart chronic hepatitis B?The Significance of Discordant Serology in Chagas Disease: Enhanced T-Cell Immunity to Trypanosoma cruzi in Serodiscordant Subjects.Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs.Authentic Patient-Derived Hepatitis C Virus Infects and Productively Replicates in Primary CD4+ and CD8+ T Lymphocytes In Vitro.Interferon-gamma-associated responses to woodchuck hepatitis virus infection in neonatal woodchucks and virus-infected hepatocytes.Recombinant Sendai virus for efficient gene transfer to human airway epithelium.Treatment of chronic hepatitis B virus infection via oral immune regulation toward hepatitis B virus proteins.Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.Evaluation of the host transcriptional response to human cytomegalovirus infection.
P2860
Q21263138-53EED451-113D-4D5E-B0EF-A2A8BD018F36Q24550676-4CE0B4DF-048F-40EF-B3B0-96CDAC27D179Q30308384-69A36E1B-5232-4120-96FD-DD5208629CDDQ30381864-89F90A3E-4038-4BF7-8B0C-87F3834ED104Q33317266-20D2CCF6-6486-416F-97C6-26881682B572Q33578063-840C0CA6-F6A3-4A16-9B54-67F3EB32F444Q33754953-0974BC13-97E8-476D-9CEF-D4F66493B4F1Q33850188-DFC6C808-5409-4FB9-86B6-740C474F037FQ34326864-3814E752-2995-4CCB-9F57-B70EC7607511Q34354287-BA1B54B2-4F5E-4632-9450-6DAE75BCA573Q34451890-82B0DB2F-D0D7-4014-9AC9-436905603DBAQ34462354-5EA0C215-D0CB-4D0C-AFA4-3E95CC37BB8DQ34540287-EAE68863-9075-4CA5-825A-A09BE42B9BBDQ34961799-23C73E23-31AF-4554-9B92-D6E742312DEFQ35209368-74AE4C7E-1EF1-418F-BB5D-42D567FB5803Q35476157-4FF179A4-F0FC-44C2-ABBF-2F19C9CC9509Q35914476-AB59D50E-0673-4DF8-8A9E-6B633C6595DBQ35947812-82FB6E74-251E-401B-9632-7A47B67278B2Q36014956-0C4F2410-08C0-476C-BFC8-38C97A1E158EQ36086627-C77FCB41-C1F4-43E0-8831-354D0B49C094Q36315044-A0EC10A0-AC13-4943-B347-FDB2D544A088Q36464809-35C4BC9C-4E8D-4874-93D4-186CE86EE475Q36845698-06449280-2BE8-4DEB-B8D0-E7427E8CF4A5Q36961739-9F356A58-C7B4-46AC-81BE-37D06C0F355CQ37127096-E09C3BDB-05AC-4250-9ED2-0376A0078057Q38209337-3D771834-3E5B-4564-AD5E-B8850775A981Q38865276-35CA8491-AC05-422F-84EF-3F7C7F4D0ADFQ39603395-78789628-0864-45FE-A16F-4952EAFE76D2Q39603723-54B646DD-9F98-4A3D-BFA5-163EFC8FB6FCQ41218683-2E1B8688-DB13-4874-958D-5EE9DB9BAF0CQ41665227-BE746A07-8B87-4EBC-AF60-5713685A27A9Q43036841-AFDAF2C8-084C-4F5C-B8BC-C44C709B2079Q45324384-025577F3-1C4D-481D-88AB-D8FFD3EE51C5Q45591313-B13FA34C-82C6-4FC5-A5B1-EA576AB18F1EQ45674713-7B911508-3902-45E9-93C9-96FBF0760276Q45708049-2B43B02D-950B-49F9-8053-8520526D8598Q45733307-9B2C13E9-D834-4197-9C62-C5773D280841Q51597552-12D83DB5-D910-4868-AE0C-C9448F00E56E
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Cytokine-mediated control of viral infections.
@ast
Cytokine-mediated control of viral infections.
@en
type
label
Cytokine-mediated control of viral infections.
@ast
Cytokine-mediated control of viral infections.
@en
prefLabel
Cytokine-mediated control of viral infections.
@ast
Cytokine-mediated control of viral infections.
@en
P356
P1433
P1476
Cytokine-mediated control of viral infections.
@en
P2093
Chisari FV
Guidotti LG
P304
P356
10.1006/VIRO.2000.0442
P407
P577
2000-08-01T00:00:00Z